M84.573
Pathological fracture in neoplastic disease, unspecified ankle
Clinical Classification Guidelines
Medical Intelligence & Overview
A pathological fracture occurs when a bone breaks due to disease weakening the bone structure, rather than from an injury or trauma. Specifically, when associated with neoplastic disease, it indicates that a tumor or cancer has compromised the bone integrity, making it more susceptible to fractures. The ICD-10 code M84.573 refers to such fractures occurring in the ankle, which are caused by underlying neoplastic diseases. Recognizing this condition is essential for proper medical management and treatment planning.
Causes & Symptoms
Clinical Causes: Primary bone tumors, such as osteosarcoma or chondrosarcoma Metastatic cancer spreading from other parts of the body, like the breast, lung, or prostate Hematologic malignancies, including lymphoma or multiple myeloma Bone infections that weaken the bone structure, though less common Prolonged use of medications like corticosteroids that can weaken bones in some cases
Key Symptoms: Sudden or gradual onset of pain in the ankle area Swelling and tenderness around the ankle Decreased mobility or difficulty bearing weight on the affected ankle Possible deformity or abnormal positioning of the ankle Persistent discomfort that worsens with activity or pressure In some cases, systemic symptoms like fatigue or weight loss if associated with underlying cancer
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and imaging studies. Physicians may perform the following tests:
Treatment Protocols: Management depends on the underlying neoplastic condition and the severity of the fracture. Typical treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M84.573 a billable ICD-10 code?
Yes, M84.573 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M84.573?
Clinical documentation must specify the nature of Pathological fracture in neoplastic disease, unspecified ankle and any associated comorbidities for accurate reporting.
Cite this Clinical Reference